Ernexa Therapeutics Analyst Price Targets - Benzinga

Ernexa Therapeutics Inc

ERNANASDAQ

Trade with Public

Trade with Public

$1.97

-0.14-6.64%

Dern. MÀJ: Oct 29, 9:06 AM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Rapport sur les stocks

Ernexa Therapeutics Analyst Price Targets - Benzinga

Ernexa Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ernexa Therapeutics (ERNA).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$30Upside to Avg. PT+1392.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 7, 2026	Brookline Capital	—	Initiate	Buy	$30

Analyst Ratings News

PRO
Brookline Capital Initiates Coverage On Ernexa Therapeutics with Buy Rating, Announces Price Target of $30

Brookline Capital initiates coverage on Ernexa Therapeutics (NASDAQ:ERNA) with a Buy rating and announces Price Target of $30.

Benzinga Newsdesk